Comparison of quality of life between melanoma and non-melanoma skin cancer patients

被引:19
|
作者
Sampogna, Francesca [1 ]
Paradisi, Andrea [2 ]
Iemboli, Maria Luisa [1 ]
Ricci, Francesco [3 ]
Sonego, Giulio [4 ]
Abeni, Damiano [1 ]
机构
[1] IDI IRCCS, Clin Epidemiol Unit, Rome, Italy
[2] Cristo Re Gen Hosp, Dermatol Unit, Rome, Italy
[3] IDI IRCCS, Melanoma Unit, Rome, Italy
[4] IDI IRCCS, Day Surg Unit, Rome, Italy
关键词
GHQ-12; melanoma; non-melanoma skin cancer; quality of life; Skindex; VERSION; CARE;
D O I
10.1684/ejd.2019.3523
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: The impact of skin cancers on patients' health-related quality of life (HRQoL) is often overlooked, and direct comparisons between melanoma and non-melanoma skin cancer (NMSC) are rare. Objectives: The aim of this study was to compare HRQoL in patients with melanoma and NMSC. Materials and Methods: Participants were unselected, consecutive adult patients with a diagnosis of melanoma at the time of wide excision, or NMSC at the time of surgery. HRQoL was measured using the two scales of Skindex-17. The 12-item General Health Questionnaire (GHQ-12) was used to identify patients with possible anxiety or depression. Results: The study population included 433 patients: 65 with melanoma and 368 with NMSC. Skindex-17 symptom mean scores were higher in NMSC than in melanoma patients. Melanoma patients had significantly higher scores for the item "feeling depressed". The percentage of GHQ-12 cases (with possible non-psychotic, minor psychiatric disorders) was significantly higher in patients with melanoma (32.8%) compared to NMSC patients (8.7%). Conclusion: NMSC places a greater burden of symptoms on patients than melanoma, while the psychological impact of melanoma is higher.
引用
收藏
页码:185 / 191
页数:7
相关论文
共 50 条
  • [31] The management of non-melanoma skin cancer
    Campbell, FA
    Gupta, G
    [J]. HOSPITAL MEDICINE, 2005, 66 (05): : 288 - 293
  • [32] Radiotherapy for Non-Melanoma Skin Cancer
    Khanh Vu
    Tai, Patricia
    Au, Joseph S. K.
    [J]. CURRENT CANCER THERAPY REVIEWS, 2016, 12 (02) : 110 - 123
  • [33] MicroRNA in non-melanoma skin cancer
    Sand, Michael
    Sand, Daniel
    Altmeyer, Peter
    Bechara, Falk G.
    [J]. CANCER BIOMARKERS, 2012, 11 (06) : 253 - 257
  • [34] Cetuximab in non-melanoma skin cancer
    Wollina, Uwe
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (07) : 949 - 956
  • [35] Photoimmunology of non-melanoma skin cancer
    Streilein, JW
    [J]. CANCER SURVEYS, 1996, 26 : 207 - 217
  • [36] Non-melanoma skin cancer in Australia
    Fransen, Marloes
    Karahallos, Amalia
    Sharma, Niyati
    English, Dallas R.
    Giles, Graham G.
    Sinclair, Rodney D.
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2012, 197 (10) : 565 - 568
  • [37] NON-MELANOMA SKIN-CANCER
    MORA, RG
    [J]. PRIMARY CARE, 1989, 16 (03): : 665 - 684
  • [38] NON-MELANOMA SKIN-CANCER
    DUVIVIER, A
    [J]. PRACTITIONER, 1984, 228 (1392) : 549 - 553
  • [39] Immunotherapy for Non-melanoma Skin Cancer
    Sophia Z. Shalhout
    Kevin S. Emerick
    Howard L. Kaufman
    David M. Miller
    [J]. Current Oncology Reports, 2021, 23
  • [40] Non-Melanoma Skin Cancer - Overview
    Joseph, Kurian
    [J]. CURRENT CANCER THERAPY REVIEWS, 2016, 12 (03) : 142 - 151